Exome Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19M | Buy |
166,944
+24,200
| +17% | +$318K | 1.63% | 22 |
|
|
2025
Q1 | $2.05M | Buy |
142,744
+5,028
| +4% | +$72.3K | 1.82% | 25 |
|
|
2024
Q4 | $2.31M | Sell |
137,716
-436
| -0.3% | -$7.3K | 1.73% | 23 |
|
|
2024
Q3 | $2.21M | Sell |
138,152
-136,748
| -50% | -$2.19M | 1.49% | 31 |
|
|
2024
Q2 | $2.48M | Hold |
274,900
| – | – | 2.21% | 21 |
|
|
2024
Q1 | $3.11M | Buy |
+274,900
| New | +$3.11M | 2.66% | 10 |
|